Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. (CRNX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CRNX · as of Sep 30, 2025
Ownership Breakdown
237
Institutional Holders
▲ 14 vs Q2
$4.49B
Total Inst. Value
▲ $1.48B vs Q2
105.44M
Shares Outstanding
freeFloat 93.01%
107.71M
13F Shares Held
▲ 3.16M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CRNX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FMR LLC pharmaceutical preparations | 14.19M | 15.13% | 15.13% | $590.91B | Nov 13, 2025 | ▲ 61.5K |
VANGUARD GROUP INC pharmaceutical preparations | 9.17M | 9.78% | 9.78% | $381.94B | Nov 7, 2025 | ▼ 86.0K |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 8.38M | 8.94% | 8.94% | $349.11B | Nov 14, 2025 | ▲ 2.57M |
BLACKROCK, INC. pharmaceutical preparations | 7.59M | 8.09% | 8.09% | $315.98B | Nov 12, 2025 | ▲ 167.9K |
DRIEHAUS CAPITAL MANAGEMENT LLC pharmaceutical preparations | 6.48M | 6.91% | 6.91% | $269.96B | Nov 14, 2025 | ▲ 81.6K |
FARALLON CAPITAL MANAGEMENT LLC pharmaceutical preparations | 5.77M | 6.15% | 6.15% | $240.32B | Feb 17, 2026 | ▲ 1.12M |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 5.31M | 5.66% | 5.66% | $221.01B | Nov 14, 2025 | ▼ 284.3K |
ECOR1 CAPITAL, LLC pharmaceutical preparations | 4.29M | 4.57% | 4.57% | $178.60B | Nov 14, 2025 | — held |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 3.86M | 4.11% | 4.11% | $160.70B | Nov 14, 2025 | ▲ 448.5K |
PARADIGM BIOCAPITAL ADVISORS LP pharmaceutical preparations | 2.55M | 2.72% | 2.72% | $106.24B | Nov 14, 2025 | ▲ 207.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
33
Increased
+8.52M shares2
New Positions
first time holders11
Decreased
−2.61M shares0
Sold Out
fully exitedNet shares change (top 50)
+5.91M
+8.52M / −2.61M
Net new holders
+24
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CRNX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
4
Sell transactions
0.75
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 222,200 | — | — | 627.0K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 111,100 | — | — | 515.9K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 222,200 | — | — | 439.0K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 111,100 | — | — | 404.8K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 222,200 | — | — | 223.2K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 222,200 | — | — | 216.8K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 80,000 | — | — | 136.8K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 111,100 | — | — | 112.1K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 111,100 | — | — | 111.1K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 80,000 | — | — | 80.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Crinetics Pharmaceuticals, Inc. (CRNX) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 6.99%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Crinetics Pharmaceuticals, Inc. is FMR LLC, holding approximately 14.19 million shares — equal to 15.13% of outstanding shares — as of September 30, 2025.
A total of 237 institutional investors currently hold CRNX stock, with a combined institutional value of approximately $4.49 billion as of the most recent 13F filing period.
Frequently asked questions
CRNX ownershipCrinetics Pharmaceuticals, Inc. (CRNX) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is FMR LLC with a 15.13% stake. Company insiders hold 6.99%. Data sourced from SEC Form 13F as of September 30, 2025.